dr. joshua m. bauml on the impact of pembrolizumab in head and neck cancer
Published 7 years ago • 133 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
0:40
dr. joshua m. bauml on pembrolizumab versus chemo in head and neck cancers
-
1:03
dr. bauml discusses immunotherapy in head and neck cancer
-
1:44
dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
-
2:22
dr. bauml discusses immunotherapy agents in head and neck cancer
-
1:26
dr. bauml on immunotherapy combinations in head and neck cancer
-
1:39
dr. bauml discusses biomarkers in head and neck cancer
-
7:35
cutting-edge immunotherapy treatment removes all traces of cancer in woman
-
7:30
what do you know about cancer immunotherapy?
-
42:53
biomarkers in cancer immunotherapy: how much do they matter?
-
1:25
dr. bauml on car t-cell therapy in head and neck cancer
-
0:58
dr. machiels on pembrolizumab in head and neck cancer
-
1:19
dr. lee on the impact of immunotherapy in head and neck cancer
-
3:08
improved survival, toxicity & qol with pembrolizumab in head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
1:40
dr. bauml on next steps for immunotherapy in head and neck cancer
-
1:59
pembrolizumab in the treatment of head and neck cancer: is there more to the story?
-
1:41
dr. bauml on keynote-055 study for patients with hnscc
-
2:08
dr. cohen discusses immunotherapy in head and neck cancer
-
1:18
dr. bauml on hpv vaccination for head and neck cancer
-
1:19
dr. jonas de souza on the impact of pembrolizumab approval in head and neck
-
1:08
biomarkers predictive of response to pembrolizumab in head and neck cancer | rtcl.tv
-
7:38
pembrolizumab shows promising activity against head and neck cancer